Controlled Release: Timing is Everything

IFF officially release a new Controlled release platform on 15th of May 2024. Here you get a deeper insight in the “Timing is Everything” platform where you can learn about pharmaceutical formulations to benefit patients and the importance of controlled release of active ingredients.

No developer of controlled release mechanisms has deeper experience, a broader record of innovations, or more controlled release products than IFF Pharma Solutions.

Our decades of multidisciplinary collaboration has equipped formulators with a wide range of drug release options. Our technologies offer optimum efficacy, safety, and reliability for customers’ APIs.

Timing is Everything

For sustaining the right level of API in the bloodstream, timing is everything. Controlled release—the ability to manage when and for how long a medication is released—has revolutionized treatment outcomes.

Pharma Solutions stands at the forefront of this innovation, offering unparalleled expertise and a legacy of excellence spanning more than 70 years.

IFF Unveils its Controlled Release Platform Featuring its Innovation and Trailblazing Excipients

Trailblazing Solutions

From creating the original METHOCEL™ CR grades for controlled release to collaborating on the first osmotic pump technology, we’ve led the way in controlled release.

Our portfolio includes METHOCEL™ CR grades, ETHOCEL™, one of the oldest and most proven excipient brands in the world—and POLYOX™, a fast swelling, versatile solution for unique challenges.

These controlled release systems are customizable for specific needs. Whether it’s matrix tablets, gastro-retentive tablets, or barrier membrane-coated pellets or tablets, we deliver solutions that optimize drug efficacy and safety.

Innovating for Tomorrow

Our commitment to innovation extends to everyday advancements and future-focused research. We continuously refine our excipients and explore new technologies to meet evolving medical needs.

Global Support

We prioritize success within the shortest time frame, bringing value to all our stakeholders.

Pharma Solutions combines building blocks for customer success:

Broad portfolio of controlled release excipients
Global supply chain efficiency
Superior technical support
Manufacturing excellence with QbD options
Premium quality and batch to batch reliability
Regulatory guidance to accelerate market delivery

IFF pharma flagship solution

From our deep portfolio of controlled release formulations and systems, here are our flagship products.

METHOCEL™

Pioneering Then, Innovating Now

Pioneering innovation is in our DNA. METHOCEL™ is the first HPMC created for the pharma market. METHOCEL™ CR grades are the original controlled release HPMC products designed to deliver consistent drug-release performance. Their range of available molecular weights and customized chemical substitutions are ideal for modulating release of APIs in the body.

ETHOCEL™

Proven Time After Time

ETHOCEL™ ethylcellulose polymers stand as durable cornerstones—maintaining their integrity in challenging environments. Not water soluble, ETHOCEL™ excels in barrier coatings that require water resistance.

POLYOX™

Versatile Across Complex and Unique Applications

It’s rare that a substance so unique has so many uses—but that’s the wonder of POLYOX™ polyethylene oxide. It’s our water soluble, free-flowing highly swellable polymer, used in complex drug delivery solutions.

Read the original text and more here

Source: IFF, Controlled Release – Pharma Solutions (iff.com)